A Phase I clinical trial presents veledimex – a drug-inducible gene therapy approach – as a promising treatment technique for glioblastoma.
Search Results: bough (31)
Researchers have identified that α-synuclein plays a role in DNA repair in neurons and that disruption of this function could lead to widespread death of neurons.
Observational studies reveal that use of sleep medications can increase an individual’s chances of developing dementia in sex-specific and race-specific ways.
Studies presented at AAIC 2019 provide potential treatment methods for the improvement of sleep quality in individuals with dementia.
The first global report on epilepsy has been published by the WHO, which calls for action to make the condition a public health priority.
Blood–brain barrier on a chip offers opportunity for personalized treatment of neurological conditions
Researchers have created a blood–brain barrier chip utilizing human induced pluripotent stem cells, which could be utilized to understand neurological disorders on a patient-to-patient basis.
Researchers have identified that the N-terminal fragment of galanin is involved in promoting anhedonia and could therefore be a potential therapeutic target for the treatment of depression.
Researchers have demonstrated that a component of bacterial cell envelopes has the ability to modulate the body’s immune response to viral inflammatory diseases.
A recent clinical trial has demonstrated that the drug, IONIS-HTTRx, is safe for use in people with Huntington’s disease.
A preliminary clinical study has demonstrated that the experimental drug tofersen may be effective in the treatment of a genetic form of ALS.